MENU
IMRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immuneering (IMRX) Ownership - Who owns Immuneering?

Immuneering Corp is a biopharmaceutical company... Show more

Profile

Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
412.6M
P/E Ratio
N/A
Total Cash
227.56M
Projected Growth
N/A
Total Debt
3.92M
Revenue
N/A
Risk (Beta)
3.59
Dividend Yield
N/A
Total Cash/Share
3.52
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

IMRX
Capitalization
413M
P/E Ratio
N/A
Risk (Beta)
3.59
Dividend Yield
N/A
Total Cash
228M
Total Cash/Share
3.52
Total Debt
3.92M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
228M
P/B Ratio
1.81
Cash Flow
N/A
Earnings
-1.79
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
63.5K
Current Ratio
24.00
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-63.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.37
Shares Held By Institutions
271M
Shares Outstanding - Current
64.6M
Total Liabilities
13.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
190.455
View a ticker or compare two or three
IMRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMRX showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
245 Main Street
Phone
+1 617 500-8080
Employees
68
Web
https://www.immuneering.com